Evercore ISI Group analyst Amit Daryanani downgrades Ciena (NYSE:CIEN) from Outperform to In-Line.
Why Is Pain Treatment Focused Heron Therapeutics Stock Trading Higher Today?
Heron Therapeutics Inc (NASDAQ: HRTX) reported Q3 sales of $31.43 million, missing the consensus of $32.75 million.